Peeling Back The Layers: Exploring Addus HomeCare Through Analyst Insights
Portfolio Pulse from Benzinga Insights
Analysts have provided diverse opinions on Addus HomeCare (NASDAQ:ADUS) with 4 somewhat bullish ratings in the past quarter. The average 12-month price target is $107.5, a slight decrease from the previous $109.50. Analysts from Oppenheimer, TD Cowen, RBC Capital, and Stephens & Co. have maintained or lowered their price targets, with the highest at $118.00 and the lowest at $102.00. Addus HomeCare has shown solid revenue growth, a high net margin, and strong ROE and ROA, with a low debt-to-equity ratio.
January 17, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Addus HomeCare received somewhat bullish ratings from analysts, with a revised average 12-month price target of $107.5. The company's strong financial performance is reflected in its revenue growth and profitability metrics.
The somewhat bullish analyst ratings and the strong financial indicators such as revenue growth, net margin, ROE, and ROA suggest a positive outlook for ADUS. The slight decrease in the average price target may temper expectations, but the overall financial health of the company supports a likely increase in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100